Los puntos clave no están disponibles para este artículo en este momento.
Persistent B cell depletion is a rare complication of rituximab treatment, mostly affecting patients with exposure(s) to cytotoxic therapies for recurrent diseases. It is characterized by prolonged disease remission and increased infection risk.
Efe et al. (Fri,) studied this question.